Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Lois Q. Semmens"'
Autor:
Xavier J. H. Pepin, Scott M. Hynes, Hamim Zahir, Deborah Walker, Lois Q. Semmens, Sandra Suarez‐Sharp
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 10, Pp 1771-1783 (2024)
Abstract Omaveloxolone is a nuclear factor (erythroid‐derived 2)‐like 2 activator approved in the United States and the European Union for the treatment of patients with Friedreich ataxia aged ≥16 years, with a recommended dosage of 150 mg oral
Externí odkaz:
https://doaj.org/article/d460f6850b8b4da5a5d2f5e21b780d1f
